Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 15, 2023

BUY
$0.39 - $0.71 $10,124 - $18,432
25,961 New
25,961 $10,000
Q2 2022

Aug 15, 2022

BUY
$1.02 - $1.83 $16,255 - $29,164
15,937 New
15,937 $18,000
Q4 2020

Feb 16, 2021

SELL
$1.15 - $2.4 $26,325 - $54,940
-22,892 Closed
0 $0
Q3 2020

Nov 16, 2020

BUY
$1.11 - $1.68 $25,410 - $38,458
22,892 New
22,892 $28,000
Q1 2020

May 15, 2020

SELL
$1.26 - $3.38 $27,793 - $74,556
-22,058 Closed
0 $0
Q4 2019

Feb 14, 2020

BUY
$0.86 - $1.44 $18,969 - $31,763
22,058 New
22,058 $30,000
Q4 2017

Feb 14, 2018

SELL
$2.99 - $4.85 $41,058 - $66,600
-13,732 Closed
0 $0
Q3 2017

Nov 14, 2017

BUY
$3.01 - $5.41 $41,333 - $74,290
13,732
13,732 $65,000

Others Institutions Holding VSTM

About Verastem, Inc.


  • Ticker VSTM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 210,000,000
  • Market Cap $1.18B
  • Description
  • Verastem, Inc., a development-stage biopharmaceutical company, focusing on developing and commercializing drugs for the treatment of cancer. Its product in development includes VS-6766, a dual rapidly accelerated fibrosarcoma (RAF)/mitogen-activated protein kinase (MEK) clamp that blocks MEK kinase activity and the ability of RAF to phosphorylat...
More about VSTM
Track This Portfolio

Track Two Sigma Securities, LLC Portfolio

Follow Two Sigma Securities, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Two Sigma Securities, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Two Sigma Securities, LLC with notifications on news.